EPAM
NVO

Euro Pacific Asset Management’s Novo Nordisk NVO Stock Holding History

Euro Pacific Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.4M Buy
467,452
+121,375
+35% +$5.75M 2.22% 16
2025
Q4 		$20.4M Buy
346,077
+67,261
+24% +$3.44M 2.26% 15
2025
Q3 		$17.5M Buy
278,816
+163,386
+142% +$9.56M 2.11% 15
2025
Q2 		$7.97M Buy
115,430
+25,273
+28% +$1.72M 1.29% 26
2025
Q1 		$6.26M Sell
90,157
-1,233
-1% -$102K 1.14% 28
2024
Q4 		$7.99M Sell
91,390
-2,820
-3% -$305K 1.72% 23
2024
Q3 		$11.1M Sell
94,210
-2,152
-2% -$287K 2.05% 23
2024
Q2 		$13.9M Sell
96,362
-2,122
-2% -$281K 2.75% 15
2024
Q1 		$12.6M Sell
98,484
-26,887
-21% -$3.2M 2.56% 18
2023
Q4 		$12.9M Sell
125,371
-2,099
-2% -$208K 2.76% 15
2023
Q3 		$11.6M Sell
127,470
-2,320
-2% -$204K 2.72% 17
2023
Q2 		$10.3M Sell
129,790
-1,508
-1% -$123K 2.26% 22
2023
Q1 		$10.5M Sell
131,298
-3,228
-2% -$229K 2.24% 22
2022
Q4 		$9.21M Sell
134,526
-2,812
-2% -$165K 2.06% 20
2022
Q3 		$6.95M Sell
137,338
-91,224
-40% -$4.89M 1.82% 26
2022
Q2 		$12.6M Sell
228,562
-5,282
-2% -$293K 2.98% 10
2022
Q1 		$13.1M Sell
233,844
-36,172
-13% -$1.86M 2.57% 19
2021
Q4 		$14.4M Sell
270,016
-2,166
-0.8% -$117K 3.24% 6
2021
Q3 		$14.5M Sell
272,182
-10,650
-4% -$515K 3.79% 6
2021
Q2 		$11.8M Buy
282,832
+35,412
+14% +$1.37M 2.89% 14
2021
Q1 		$8.42M Sell
247,420
-7,552
-3% -$269K 2.16% 20
2020
Q4 		$9.04M Buy
254,972
+442
+0.2% +$15.3K 2.19% 20
2020
Q3 		$8.84M Sell
254,530
-978
-0.4% -$32.6K 2.24% 18
2020
Q2 		$8.38M Sell
255,508
-9,098
-3% -$290K 2.34% 18
2020
Q1 		$8.36M Sell
264,606
-53,934
-17% -$1.61M 2.77% 12
2019
Q4 		$9.19M Buy
+318,540
New +$8.82M 3.32% 10

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Euro Pacific Asset Management's NVO Position: Q1 2026 in Review

Euro Pacific Asset Management increased its Novo Nordisk (NVO) stake by 35% in Q1 2026, buying an estimated $5.75M and bringing the position to 467,452 shares worth $22.4M. The position accounts for 2.22% of the portfolio, ranked #16.

Euro Pacific Asset Management first reported a position in NVO in Q4 2019 and has held it in 26 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Euro Pacific Asset Management held 467,452 shares of Novo Nordisk worth $22.4M as of Q1 2026.
  • Euro Pacific Asset Management bought 121,375 Novo Nordisk shares in Q1 2026, an estimated $5.75M.
  • Novo Nordisk made up 2.22% of Euro Pacific Asset Management's portfolio in Q1 2026, its #16 holding.
  • Euro Pacific Asset Management first reported a position in Novo Nordisk in Q4 2019 and has held it in 26 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Euro Pacific Asset Management's 13F filing for Q1 2026, filed 6 May 2026.